Form 4: Relay Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4
Thomas Catinazzo, CFO of Relay Therapeutics, sold 1,695 shares of common stock on April 29, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, sold 1,695 shares of common stock on April 29, 2024.
- The sale was executed at a price of $6.38 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 5,722 restricted stock units (RSUs) on April 27, 2024.
- Following the transaction, Catinazzo beneficially owns 339,803 shares, including 305,921 shares underlying RSUs.
- The sale was conducted in accordance with Relay Therapeutics' policies regarding the vesting of RSUs, and Catinazzo had no discretion over the sale.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects a routine transaction to cover tax obligations, which is a normal part of executive compensation.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This particular filing reflects a common practice of selling shares to cover tax obligations upon the vesting of RSUs.
Key Dates
| Date | Description |
|---|---|
| 04/27/2024 | Vesting date of 5,722 restricted stock units (RSUs). |
| 04/29/2024 | Date of the stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.